4 ms·

You did not include the most relevant part of the paper's abstract: > We did not observe an increased incidence of neither pericarditis nor myocarditis in adul

by baxtr 4y ago

You did not include the most relevant part of the paper's abstract: > We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.

someNameIG 4y ago
I was more just pointing out that this was in the recovery phase, not during the acute infection. I've seen people use this paper as evidence that a covid infection does not increase the risk of CV incidents. And this seems to be an outlier anyway: > In conclusion, either symptomatic or asymptomatic SARS-CoV-2 infection is associated with an increased risk for late CV outcomes and has a causal effect on all-cause mortality in a late post-COVID-19 period. https://www.ajconline.org/article/S0002-9149(22)00655-5/fulltext https://www.ajconline.org/article/S0002-9149(22)00655-5/full... > In summary, using a national cohort of people with COVID-19, we show that risk and 12-month burden of incident cardiovascular disease are substantial and span several cardiovascular disease categories (ischemic and non-ischemic heart disease, dysrhythmias and others). The risks and burdens of cardiovascular disease were evident even among those whose acute COVID-19 did not necessitate hospitalization. https://www.nature.com/articles/s41591-022-01689-3 https://www.nature.com/articles/s41591-022-01689-3 > The 12-month risk of incidental cardiovascular diseases is substantially higher in the COVID-19 survivors than the non-COVID-19 controls. Clinicians and patients with a history of COVID-19 should pay attention to their cardiovascular health in long term. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00349-2/fulltext https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...
- rgrieselhuber 4y ago
  > First, we censored cohort participants at the time of receiving the first dose of any COVID-19 vaccine. Second, we adjusted for vaccination as a time-varying covariate. What does this mean, specifically?

by baxtr 4y ago

someNameIG 4y ago

I was more just pointing out that this was in the recovery phase, not during the acute infection. I've seen people use this paper as evidence that a covid infection does not increase the risk of CV incidents. And this seems to be an outlier anyway: > In conclusion, either symptomatic or asymptomatic SARS-CoV-2 infection is associated with an increased risk for late CV outcomes and has a causal effect on all-cause mortality in a late post-COVID-19 period. https://www.ajconline.org/article/S0002-9149(22)00655-5/fulltext https://www.ajconline.org/article/S0002-9149(22)00655-5/full... > In summary, using a national cohort of people with COVID-19, we show that risk and 12-month burden of incident cardiovascular disease are substantial and span several cardiovascular disease categories (ischemic and non-ischemic heart disease, dysrhythmias and others). The risks and burdens of cardiovascular disease were evident even among those whose acute COVID-19 did not necessitate hospitalization. https://www.nature.com/articles/s41591-022-01689-3 https://www.nature.com/articles/s41591-022-01689-3 > The 12-month risk of incidental cardiovascular diseases is substantially higher in the COVID-19 survivors than the non-COVID-19 controls. Clinicians and patients with a history of COVID-19 should pay attention to their cardiovascular health in long term. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00349-2/fulltext https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...

rgrieselhuber 4y ago
> First, we censored cohort participants at the time of receiving the first dose of any COVID-19 vaccine. Second, we adjusted for vaccination as a time-varying covariate. What does this mean, specifically?